IRIS Accounts Production v24.3.2.46 09559905 director 1.5.23 30.4.24 30.4.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh095599052023-04-30095599052024-04-30095599052023-05-012024-04-30095599052022-04-30095599052022-05-012023-04-30095599052023-04-3009559905ns15:EnglandWales2023-05-012024-04-3009559905ns14:PoundSterling2023-05-012024-04-3009559905ns10:Director12023-05-012024-04-3009559905ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3009559905ns10:SmallEntities2023-05-012024-04-3009559905ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3009559905ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3009559905ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3009559905ns10:FullAccounts2023-05-012024-04-3009559905ns10:CompanySecretary12023-05-012024-04-3009559905ns10:RegisteredOffice2023-05-012024-04-3009559905ns5:CurrentFinancialInstruments2024-04-3009559905ns5:CurrentFinancialInstruments2023-04-3009559905ns5:ShareCapital2024-04-3009559905ns5:ShareCapital2023-04-3009559905ns5:RetainedEarningsAccumulatedLosses2024-04-3009559905ns5:RetainedEarningsAccumulatedLosses2023-04-3009559905ns5:ComputerEquipment2023-04-3009559905ns5:ComputerEquipment2023-05-012024-04-3009559905ns5:ComputerEquipment2024-04-3009559905ns5:ComputerEquipment2023-04-3009559905ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3009559905ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 09559905 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2024

FOR

METAPHARM LIMITED

METAPHARM LIMITED (REGISTERED NUMBER: 09559905)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


METAPHARM LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2024







DIRECTOR: Hitesh Mehta





SECRETARY: Mrs Sapna Mehta





REGISTERED OFFICE: 364-368 Cranbrook Road
Gants Hill
Ilford
Essex
IG2 6HY





REGISTERED NUMBER: 09559905 (England and Wales)





ACCOUNTANTS: Prestons
Chartered Accountants
364-368 Cranbrook Road
Gants Hill
Ilford
Essex
IG2 6HY

METAPHARM LIMITED (REGISTERED NUMBER: 09559905)

STATEMENT OF FINANCIAL POSITION
30 APRIL 2024

30.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 217 289

CURRENT ASSETS
Debtors 5 3,558 3,797
Cash at bank 68,666 55,718
72,224 59,515
CREDITORS
Amounts falling due within one year 6 32,061 26,841
NET CURRENT ASSETS 40,163 32,674
TOTAL ASSETS LESS CURRENT
LIABILITIES

40,380

32,963

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 39,380 31,963
SHAREHOLDERS' FUNDS 40,380 32,963

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

METAPHARM LIMITED (REGISTERED NUMBER: 09559905)

STATEMENT OF FINANCIAL POSITION - continued
30 APRIL 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 January 2025 and were signed by:





Hitesh Mehta - Director


METAPHARM LIMITED (REGISTERED NUMBER: 09559905)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1. STATUTORY INFORMATION

Metapharm Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Tangible fixed assets
Tangible fixed assets are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.
Depreciation is charged so as to allocate the costs of assets less their residual value over their estimated useful lives, using either a straight line or reducing balance method, as indicated below.
Depreciation is provided on the following basis:

Computer Equipment - 25% Written Down Value

The asset's residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit and loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


METAPHARM LIMITED (REGISTERED NUMBER: 09559905)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 May 2023
and 30 April 2024 1,809
DEPRECIATION
At 1 May 2023 1,520
Charge for year 72
At 30 April 2024 1,592
NET BOOK VALUE
At 30 April 2024 217
At 30 April 2023 289

METAPHARM LIMITED (REGISTERED NUMBER: 09559905)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 3,558 2,832
Other debtors - 965
3,558 3,797

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Taxation and social security 1,757 902
Other creditors 30,304 25,939
32,061 26,841